Register for SOSV’s HAX demo days in San Francisco (4/29) and Newark (5/6)
Back
Announcing SOSV’s Biomanufacturing VC-Founder Matchup – April 21-25, 2025 (Virtual, Free)
Back
Ben Joffe
Ben Joffe
March 28, 2025

Welcome to the Biomanufacturing Matchup Event, where biology meets bold ambition.

EXPECTED > 200 startups | 200 investors | 1 week of virtual meetings | Free
UPDATE (APR.14) > There are already 250+ startups and 250+ investors registered!

From sustainable jet fuel to protein production, from next-gen pharmaceuticals to high-performance biomaterials—there are few limits to what can be manufactured with biology today. 

As global demand accelerates for sustainable, high-performance, and planet-positive products, startups across health, food, energy, agriculture, beauty, and materials are answering the call—with biology as their engine.

This virtual matchmaking event brings together the innovators and the investors driving that shift. Whether you’re refining enzyme pathways, developing novel bioreactors, reimagining cell therapies, or scaling biomanufacturing infrastructure—you’ll find aligned minds (and money) here.

The event is 100% free and open to all investors and founders in the category. We expect about 200 startups and 200 investors to join this inaugural event on biomanufacturing.

Registration

Startup Registration | Investor Registration

  • March 28 – Registration opens
  • April 14 – Meeting requests open
  • April 21-25 – Meetings take place 

More details below. 

What Are VC-Founder Matchups?

WHAT > SOSV Matchups are VIRTUAL, GLOBAL and FREE matchmaking events focused on specific themes and open to all investors and all early stage founders worldwide.

WHY > Better connect the investor-founder ecosystems related to human and planetary health.

SCALE > From 100 to 1000+ participants depending on theme. Since 2022, 2,000+ investors and 3,000+ founders have participated. 

RESULTS > Feel your market, find investors, find investments. Many thousands of meetings and numerous investments took place already. SOSV alone invested in 8 startups discovered during matchups.

DURATION > Typically run over a week,  making it easier to place 20-min meetings at convenient times.

CURATION > Registration requires a high level of detail from participants. This enables better targeting of meetings.

PROCESS > Matchups are “self-service”. Participants reach out to set up meetings.

Who Should Attend

For this inaugural event, we expect 200 startups and 200 investors. Many of our other matchups exceeded those numbers, with up to 1,000+ participants.

  • Startups: Startups focused on Biomanufacturing, from pre-seed up to series B.
  • Investors: VCs, CVCs, FOs, syndicates and angel investors with a checkbook.
  • Nobody else, please: Service providers, this event is not for you.

What to Expect

  • Many High Quality Participants: A typical matchup attracts the top founders and investors in the ecosystem. 
  • 100% Matchmaking: No talks or panels. The Matchup is a unique opportunity to identify and connect quickly and efficiently with relevant founders and investors.
  • Detailed Startups Profiles: Filter startups easily according to their sector, location, funding stage and more.
  • Detailed Investors Profiles: Find who focuses on your sector, stage and geography.

FAQs

Q: Why are matchups one week long?

Q: What is the duration of meetings?

Q: How many meetings can I book?

Q: I’m a founder. No one is responding to my requests.

Q: I’m a founder. Should I include my pitch deck?

Q: The platform is not convenient. Can I connect outside?

Past Participants

Past participants include prominent VC and CVC firms such as:

3M Ventures, 8VC, AlleyCorp, ARCH Venture Partners, Astanor Ventures, BASF Venture, Box Group, Bessemer Venture Partners, Bosch Ventures, Cargill, Coatue Management, Collaborative Fund, Counteract, DCVC, Dow, Ecosystem Integrity Fund, Global Brain, H&M Group Ventures, Honda Xcelerator Ventures, In-Q-Tel, Joyance Partners, Khosla Ventures, Illumina Ventures, Main Sequence Ventures, Merck, Plum Alley, Ponderosa Ventures, Prelude Ventures, ReGen Ventures, Rhapsody Venture Partners, Siemens, Sony, Speedinvest, Stanley Ventures, Sumitomo Corporation of Americas, Systemiq Capital, The Engine Accelerator, Touchdown Ventures, Verge HealthTech Fund, Wavemaker 360 .

How to Get Involved

Stay tuned for registration details and agenda updates for each Matchup. We can’t wait to see you at one—or all—of our 2025 Matchups!

Sign up to SOSV’s newsletter to hear about upcoming events.

Did you know?

How Ten63 turned an academic project into an AI platform for drugging “undruggable” cancers

Bruce Donald, Marcel Frenkel and Mark Hallen are analyzing over 19,290,123 compounds per second at quantum accuracies to develop drugs to previously incurable cancers.

unspun’s Weaving Machines Aim to Fix Apparel’s Waste and Carbon Problem

Funded with $57 million from DCVC, Lowercarbon Capital and SOSV, among others, unspun aims to eliminate 1% of global carbon emissions

NotCo’s plant-based foods are on store shelves, but its AI engine “Giuseppe” is the real business

While it might look like a plant-based food company, NotCo is in the data and AI business—and aims to disrupt R&D in many industries that use animal and plant ingredients.

Smartex is Creating the Textile Factory of the Future

Gilberto Loureiro grew up inspecting fabrics in a Portuguese textile factory. With Smartex, he and co-founders Antonio Rocha and Paulo Ribeiro are eliminating textile defects—and their enormous cost both to manufacturers and the environment.

Novoloop Is Upcycling Your Future

Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.

Upside Foods Serves Up a Sustainable Future

To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.

Sleeping Beauty

In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.

The Loneliness of the Long-Distance Entrepreneur

In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.

Chiu Chau Reboots a Robot into a Billion Dollar Business

It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.

RxAll’s Life-Saving Deep Tech for African Pharmacies

Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.